Pharming Group's Upcoming Investor Conferences in September
Leiden, the Netherlands: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is thrilled to announce its active participation in key investor conferences across the U.S. this September. This effort is designed to enhance connections with the investment community and share valuable insights into the company’s exciting developments.
Details on the Wells Fargo Healthcare Conference
One of the key events is the 2024 Wells Fargo Healthcare Conference, which will be held in Boston from September 4 to 6. At this conference, Sijmen de Vries, the Chief Executive Officer, will take part in a fireside chat, which includes a Q&A session on Friday, September 6, at 08:45 AM ET. This engaging platform will allow investors to gain a deeper understanding of Pharming's mission and its ongoing projects. A live webcast, along with a replay of this session, will be available on Pharming’s official website.
Participation in the H.C. Wainwright Global Investment Conference
After the Wells Fargo event, Pharming will also be involved in the H.C. Wainwright 26th Annual Global Investment Conference, scheduled to take place in New York from September 9 to 11. During this conference, Sijmen de Vries will present updates and findings on Monday, September 9, at 10:30 AM ET. Similar to the previous conference, a live webcast and replay will be accessible on the Pharming website, allowing investors who are unable to attend in person to engage with the content.
Engaging with Pharming’s Management Team
Investors who wish to learn more about the conferences or arrange a one-on-one meeting with Pharming’s management team can easily reach out to the Investor Relations team. They are available via email at investor@pharming.com or through your Wells Fargo or H.C. Wainwright representatives. This is a wonderful opportunity to connect directly with the leaders driving innovation in biopharmaceuticals.
About Pharming Group N.V.
Leading Innovation in Biopharmaceuticals
Pharming Group N.V. is a well-respected biopharmaceutical company committed to enhancing the lives of patients facing rare and life-threatening diseases. Headquartered in Leiden, the Netherlands, Pharming has a dedicated workforce focused on commercializing and advancing a broad range of protein replacement therapies and precision medicines. Their unwavering commitment has enabled them to serve patients in over 30 markets worldwide, spanning North America, Europe, the Middle East, Africa, and Asia-Pacific.
Stay Updated
For more information on Pharming’s latest news and investor relations, visit their official website to explore their extensive portfolio of initiatives. They are devoted to transforming patient care and continuously strive to bring innovative solutions to the forefront.
Frequently Asked Questions
What events is Pharming Group participating in this September?
Pharming Group will participate in the Wells Fargo Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference in September.
Who will represent Pharming Group at these conferences?
Sijmen de Vries, the Chief Executive Officer, will represent Pharming Group at both conferences.
How can investors connect with Pharming's management?
Investors can contact Pharming’s Investor Relations team via email at investor@pharming.com to arrange one-on-one meetings or ask additional questions.
Where is Pharming Group headquartered?
Pharming Group N.V. is headquartered in Leiden, the Netherlands.
What is the focus of Pharming Group's portfolio?
Pharming focuses on developing and commercializing innovative protein replacement therapies and precision medicines for patients with rare diseases.